Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Titan's Patents are CRUCIAL to locking up Single Port and the way they do it. There are many critical and valuable patents that Titan holds(snake arms, wrist roll, etc), however IMO the most valuable is the patent they hold on the camera and visualization on the insertion tube. Being able to visualize and map out the surgical site prior to insertion of instruments means that no other company can have that capability without infringing on Titan's patents. An example is Intuitives daVinci SP does not have that capability and therefore will be inferior to Titan Medical's SPORT Platform
https://www.upcounsel.com/is-intellectual-property-an-intangible-asset
Today is 9/9/19 - Medtronic makes announcement on their surgical robotic platform on 9/24/19 - 15 DAYS FROM NOW.
If I sell today, I will have to wait 30 days to avoid the penalties of a WASH SALE, which means that I have to wait until Oct. 21 to BUY BACK WITHOUT PENALTY.
Too much risk to take for me, I think I will hold off selling b/c any solid news will send the PPS up.
What else do they need for CE mark?
Titan has all it needs right now for regulatory approval. CE MARK is just as good as FDA 510k
Are u saying that Randall is your guide to knowledge about Titan....LOL, LMAO. Holy crap man, are u clueless!!!!!! LMAO
Wash Sales rules prevent one from selling Titan Medical and buying back within 30 days. Sell on Monday and you can’t buy back until mid-late October. Is that a risk worth taking?
U are uninformed regarding in house IP value.
There is no value on the books. The post u r referring to is the money that have paid Knobbe Martens to help prosecute their patents and their ENOS trademark. BTW, knobbe martens also prosecutes Auris ‘s patents, thanks for pointing out connection bt JNJ and Titan.
That’s is absolutely false. Patents developed in-house have no value on the books but are have tremendous value as an M&A target.
From Titan Medical - David McNally
"Looking forward, we plan to lease a facility in Chapel Hill, North Carolina during the third quarter to house our U.S. operations, including the team that will manage engineering and manufacturing, technical support, quality, customer service, training, clinical support and, ultimately, commercialization. The location is close to our product development partners and has access to the significant talent that resides in this medical technology hub. Importantly, the facility will include a dry lab to host surgeon training following product launch."
Interesting that JNJ is hiring for these type of people in Chapel Hill
REal simple, if I take your advice and sell now, I could risk losing over 50% of my shares (remember sell at $1.20 and buy back in at 70 cents). You CAN NOT GUARANTEE that the PPS goes down and I am restricted by wash sales rules so even if on Sept 25th, I bought everything back MY COST AVERAGE GOES UP AND I HAVE LESS SHARES.
You do what you want with your money, short it, by the F warrants, gamble it on the golf course, wipe your ass, i don't care.
This sector is heating up and all it takes is one sniff of something big and PPS will shoot up. Remember the false rumors that longtermgems and his cronies put out about TRXC, stock shot up and that was a POS.
If you are a long and have averaged down to this point - it would be insane to risk it for a couple of extra hundred shares but you do what you want with your own money. As for what I am doing with mine is holding on b/c we are at the top of the roller coaster and its about to go.
JnJ/Titan/Verb/Auris
Titan doesn't have to issue one more share to Aspire if they don't want - that is why the terms of the agreement were so favorable to Titan. If Aspire dumps the shares this week, Titan already got the money so what the PPS will drop..?.? Ok they dump ALL THEIR shares this week, PPS will go down to $1.80 at the most.... So they dump this week, PPS goes down, Titan has their cash, they announce partners, IDE Submittal, etc right around Sept 24th and the PPS rebounds and moves north of $4. Titan can go to the shelf and do a private placement from the $125M in money they have from the approved shelf.
And Titan doesn't have to agree to one more share to Aspire.
Let's see if they dump this week, IF THEY DUMP IT ALL PPS WILL GO TO $1.80....
All of that for about a $300k profit....if they just held on to that they would make $30M on this first financing in 12 months.
Stryker again making a move in surgical robotics - Titan is worth 5x this RIGHT NOW with the patents and regulatory approval just months away.
https://www.massdevice.com/stryker-bolsters-robotics-play-with-500m-offer-for-mobius-imaging/
Medtronic releasing the SINGLE PORT Platform on 9/24 - seems real risky to sell until everyone gets a peek behind the curtain - sell now, have to wait until Oct 16th to buy back with wash sale repercussions.
https://www.massdevice.com/medtronic-readies-device-to-rival-da-vinci-sp/
I can't believe anyone that has any sanity would risk selling now when they are so close to seeing Medtronic's SINGLE PORT platform
Also, Medtronic's top surgical robotic executive just left them to "join" Titan. Very interesting how Medtronic just "let him leave" without any pushback, especially considering they will be showing their platform in 17 days.
Titan Medical opening a US Headquarters in Chapel Hill, NC.
JNJ is currently hiring people for Chapel Hill, NC.........
Found JNJ engineer working w Titan on their SPORT platform.
17 days until Medtronic shows its hand. Sell on Monday and to avoid wash sale penalty one will have to buy back on October 15th. Is it worth the risk? Hey if you believe it will go to $1 b/t now and Oct 15th, might have to think about selling. You do have 30 trading days and Titan could be part of Medtronic's platform or maybe JnJ decides to partner. IDE Submittal will definitely happen before October 15th. Possible that Titan announces who their endoscope supplier is or finally announce the WW supplier of end effectors since we know it isn't Microline. THey should announce the CRO, they should announce who their IDE sponsor is (has to be a biggun - could stryker come into the mix).
They also have to do their rebranding, all of this is possible in Q4 and we are 3 weeks from Q4. Investing is like gambling, i guess everyone has to ask themselves how much risk is involved in gambling. I doubt it will go down to $1...sell now at $2 and hope it goes down but if it does and one is lucky enough to buy back in after wash sale and it is at $1.80, you would be fortunate to get about 10% more in shares BUT if you sell at $2 and it goes up to $3 before October 15, you would lose 50% of your shares.....is it worth the risk and are you going to let other people dictate what you do with your hard earned money...you shouldn't, its your money.
Shorts again working very, very hard and got this board up to over 100 posts yesterday, great work....here comes $1, you guys can do this, I have to believe that a Titan PR to announce the time change of an upcoming presentation would have only helped the cause. BUT TO ONLY DROP A COUPLE OF PENNIES TODAY and having a time change PR hold shorts at bay...very disappointing. I am in this for the long and the buyout in 12 months so I have all the time in the world (actually 12 months) to sit back and watch to see if they can pull this off to get to $1. Maybe next week it will go to $1 BUT another day down and we are trading north of $2.
Titan just got $35M in funding, still has access to $125M in shelf - fully funded and within 6 months of regulatory submission. Going to be interesting to see what happens on Sept 24th......
Only 11 trading days until Sept 24th and the big reveal by Medtronic. Sell now and 30 trading days of wash sale takes effect which means no buy back until OCTOBER 14th. Imagine if Medtronic annoucnes they have partner with Titan to include in their Einstein Surgical Robotic Platform as their SINGLE PORT Offering. It would explain Chad Zaring taking the top role at Titan. It would also cause the PPS of Titan to go to over $20/share by Oct 1. Again, WASH SALE prevents you from buying back in until October 14th.
If you sell your 10000 shares at $2 NOW and have to buy back in at $20 after WASH SALE, you would have 1000 shares..... I guess that is the risk you have to decide if your willing to take....
IF they want to compete with ISRG, Medtronic will need SINGLE PORT - we shall see. It will be interesting to see what JnJ unveils on Sept 24 as well....
And that is the beauty of the deal that Titan just struck for $35M from ASPIRE. They can dictate exactly when they want the funds so when PPS is at $5 in November, Titan can request $5M and only dilute 1M shares, just a fraction of the overall shares outstanding. HH777 is saying 96M shares outstanding and 1M is just over 1%. MINIMUM DILUTION - great deal for Titan Medical.
The company should absolutely disclose who is making the end effectors per the 2015 PR announcing the agreement. We have confirmed it is not Microline.
Yes, you are correct, Titan just got $35M in funding from Aspire Capital
18 days until Sept 24th but if one sells now, they will have to wait 30 days to avoid wash sale implications - since no one knows what Medtronic or JnJ will be doing on the 24th, its a big risk to sell now, all IMO.
More feedback on Titan's SPORT from an expert robotic surgeon:
Jelle Ruurda, MD, a gastrointestinal and oncologic surgeon at University Medical Center Utrecht, who has several years of robotic surgery experience, commented, “Many oncologic general surgery procedures require specimen retrieval at the end of the procedure. These procedures are natural applications for single-port robotic surgery. My first operation of the SPORT system in a preclinical environment was very exciting, and the system shows great promise for future clinical use. I look forward to the opportunity to work together with Titan Medical to evolve a single-port robotic surgery option for my oncology patients. Based on this first experience, I am confident that single-port robotic surgery has a bright future”.
What Constitutes a Wash Sale
Stocks or securities of one company are generally not considered substantially identical by the IRS to those of another. As well, the bonds and preferred stock of a company are also ordinarily not considered substantially identical to the company’s common stock. However, there are circumstances in which preferred stock, for example, could be considered substantially identical to the common stock. This would be the case if the preferred stock is convertible into common stock without any restriction, has the same voting rights as the common stock, and trades at a price close to the conversion ratio.
If the loss is disallowed by the IRS because of the wash-sale rule, the taxpayer has to add the loss to the cost of the new stock, which becomes the cost basis for the new stock.
For example, consider the case of an investor who purchased 100 shares of Microsoft for $33, sold the shares at $30, and within 30 days bought 100 shares at $32. In this case, while the loss of $300 would be disallowed by the IRS because of the wash-sale rule, it can be added to the $3,200 cost of the new purchase. The new cost basis, therefore, becomes $3,500 for the 100 shares that were purchased the second time, or $35 per share.
Understanding Wash-Sale Rule
The intent of the wash-sale rule is to prevent taxpayers from claiming artificial losses. Conversely, if a taxpayer were to register a gain by selling securities, and within 30 days they were to buy identical replacement securities, the proceeds from that transaction would still be taxable. The sale of options (which are quantified in the same ways as stocks) at a loss and reacquisition of identical options in the 30-day timeframe would also fall under the terms of the wash-sale rule. So the wash-sale period is actually 61 days, consisting of the 30 days before to 30 days after the date of sale.
Wash-Sale Rule Example
For example, you buy 100 shares of XYZ tech stock on November 1 for $10,000. On December 15, the value of the 100 shares has declined to $7,000, so you sell the entire position to realize a capital loss of $3,000 for tax deduction purposes. On December 27 of the same year, you repurchase the 100 shares of XYZ tech stock back again to reestablish your position in the stock. The initial loss will be not be allowed to be counted as a tax loss since the security was repurchased within the limited time interval.
18 days until Sept 24. Sell now and you will have to wait 30 days or a wash sales takes effect.
Curious that REBRANDING timeline has not changed.
$35M in funding from Aspire (on great terms for Titan Medical)
JNJ/Titan/Verb/Auris
JnJ/Titan/Verb/Auris
September 24th!!!!! Medtronic is announcing their platform. What else is going on September 24th? Very interesting stuff....
Please articulate, not even sure what you are talking about with this post....
I am expecting Medtronic to showcase their Surgical Robotic Platform and wondering if they will be showcasing:
Multi port
Single port
Endoluminal
They will need all three to compete with Intuitive
Based off what Medtronic is doing in robotics and it will be the future of Medtronic, sure is odd that Zaring leaves a top level position in Medtronics Robotics division to go to Titan Medical Inc and their SINGLE PORT platform.
I would guess that it will be a hard uphill battle for Zaring and Titan to try and compete with not only Intuitive's SP platform but now having to compete with Medtronic's SINGLE PORT platform.....just wondering which Single Port platform Medtronic has or will acquire....
#TMDI
#SINGLEPORT
#SINGLE-PORT
#ROBOTICSURGERY
#SURGICALROBOTICS
#JNJ
#VERBSURGICAL
#MEDTRONIC
Sure might want to hold off selling until you see what Medtronic has on Sept 24.
https://www.fool.com/investing/2019/09/05/is-medtronic-about-to-give-intuitive-surgical-a-ru.aspx
This guy took some massive losses on investments from time to time - he must suck and have no idea on how to invest b/c these couple of times it didn't pan out.....
https://www.cnbc.com/2017/12/15/warren-buffetts-failures-15-investing-mistakes-he-regrets.html
66, HC777 has been very transparent that he is shorting the stock and needs it to go down to cover. Whether it is shady math on the Aspire pricing or just telling people to sell at one point and buy back later to acquire more shares. That is straight out of the playbook that shorters use to legally work the system. Sell now at $1.20 and buy back at 70 cents.... Sell now at $2, take the tax loss, wait 30 days and buy back in at $1.
Bottom line is that they think they have all the time in the world to work this over and they do have some BUT we are close enough to the end that ANYTHING can happen at ANYTIME.
Sell now - wash sale applies and will have to wait 30 days until buying back in. IDE sumbittal is in less then 30 days.
We have 19 days to Medtronic unveiling their surgical robotic platform so at the least, anyone who is thinking of selling should wait for Sept 24th to see what Medtronic has.
Aspire is a legitimate and reputable firm that runs a successful business - strategy posted on an anonymous chat room rarely leads to running a successful business. I would venture to guess that if ASPIRE is going to fund Titan Medical Inc with $35M - they see the long term potential and value being created.
Aspire has done their due diligence and also realizes that if ANY BIGGUN wants to compete with ISRG - they will need SINGLE PORT and Titan has it so a biggun will have to pay for it.
I also can't believe that ISRG is completely dropping the ball on this - they COULD ABSOLUTELY STEAL THIS and wrap up Single Port Robotic Surgery for 20 years, 20 YEARS!!!! It is amazing how arrogant they are that they can't see the forest thru the trees.